All National Institute for Health and Care Excellence (NICE) articles
See all articles with this subject.
-
CommentLet's create a NICE for workforce
Future proofing the workforce needs to go beyond regulating titles protected in law, writes Elaine Maxwell
-
Expert Briefing
West Country Chronicle: The NHS is failing to diagnose Devon’s autistic children
From Cornwall to the Cotswolds, West Country Chronicle offers essential insight into NHS matters in the South West. Contact me in confidence here .
-
Expert Briefing
Mental Health Matters: Trusts to review use of controversial care model
HSJ’ s fortnightly briefing covering safety, quality, performance and finances in the mental health sector — contact me in confidence .
-
Expert Briefing
Mental Health Matters: Celebrity death among cascade of concern over eating disorders
HSJ’ s fortnightly briefing covering safety, quality, performance and finances in the mental health sector — contact me in confidence .
-
Expert Briefing
Mental Health Matters: Kicking the can down the road
HSJ’ s fortnightly briefing covering safety, quality, performance and finances in the mental health sector — contact me in confidence .
-
Expert Briefing
The Integrator: ‘No urgency, no plan’ for long covid
Insider tales and must-read analysis on how integration is reshaping health and care systems, NHS providers, primary care, and commissioning. This week by senior correspondent, Sharon Brennan.
-
News
‘No capacity anywhere’ to deal with unprecedented surge in children’s mental health demand
There is ‘no capacity anywhere’ to deal with an unprecedented surge in admissions of children with mental health problems, a senior clinician has told HSJ .
-
Comment
Evaluation of service transformation needs more money, staff and focus
There is a need to change how rapid service evaluation is funded, co-ordinated and delivered, not just during but beyond the pandemic to enable more effective scale-up of health and care innovations, writes Prof Mike Roberts
-
Comment
We need a more productive and sustainable relationship between the NHS and the life sciences industry
The relationship between the life sciences industry and its health system partners is sub optimal because the ambitions, constraints and risk appetites of the organisations involved in it are not sufficiently aligned. Change is needed to ensure that innovative new technologies get to patients quickly, argue Andrew Dillon and colleagues ...
-
News
‘Suboptimal’ relationship between NHS and pharma needs ‘urgent’ attention, says ex-NICE chief
The relationship between the NHS and the pharmaceutical sector is ‘suboptimal’ because of the misalignment of ‘ambitions, constraints and risk appetites’, according to former National Institute for Health and Care Excellence Sir Andrew Dillon.
-
Comment
Taking back control? Not quite
The forthcoming white paper should be cautiously welcomed. While not perfect, these proposals to enhance political accountability are long overdue, writes Robert Ede.
-
Comment
PHE's abolition is an 'opportunity for councils to take the lead'
An enhanced sector-led improvement approach, where councils are responsible for their own performance and are held accountable locally, not nationally, would be a cost-effective way to boost public health, argues Cllr Ian Hudspeth
-
News
Exclusive: Trusts offering controversial trauma ‘treatment’ to new mums
Several NHS trusts are offering a ‘treatment’ for birth trauma which uses a technique which lies outside national guidelines and which is criticised by specialists as potentially causing ‘more harm than good’.
-
HSJ Partners
Could we do better in type 2 diabetes?
Current NICE guidelines on type 2 diabetes do not consider the benefits of early introduction of more modern and expensive glucose-lowering therapies, notes Stephen C Bain
-
Comment
Gov medical advisors should resign or speak out over England’s failing covid strategy
Regulatory policies need appointment processes and employment contracts which make the freedom to speak out, a genuine independence for medics. By David Oliver
-
HSJ Partners
Gene Therapy – will the NHS lead or follow?
In a four-part series, Bluebirdbio is exploring how the NHS can embrace the power of gene therapy as a treatment for rare diseases in the UK, including some of the systemic changes that will be needed. In this fourth and last column, Ross Selby, MRPharmS, Bluebirdbio UK’s Access, Value and ...
-
Comment
How CVDprevent will close the gap on poor primary care performance
The national audit for cardiovascular disease will include six high risk conditions with extracts of routinely recorded general practice data being monitored and managed for reducing impact on patients. By Dr Matt Kearney and Lorraine Oldridge.
-
News
Arm’s length bodies show ‘very little improvement’ on diversity
Arm’s length bodies in the NHS made virtually no improvement in the numbers of BAME staff at the highest levels in 2019, according to new official data.
-
News
HSJ80 full list: The most influential people in health
The HSJ80 lists the figures who will exercise the most power and/or influence in the English NHS and health policy over the next 12 months
-
News
HSJ100: Exclusions
Based on the results of the last 15 years, we have drawn up an exclusion list of leaders who were certain to be part of our list, allowing a deeper dive beyond them
